Uploaded January 2018 | Updated September 2026, 10 hours ago
Dr. Harrington being interviewed at the AMMG's 23rd Clinical Applications for Age Management Medicine Conference.
Doug Harrington, M.D.
Clinical Professor of Pathology, USC Keck School of Medicine, Los Angeles, CA
CEO & Lab Director, Global Discovery Biosciences, Irvine, CA
Dr. Douglas Harrington has over 25 years of experience in the research, development, commercialization, and expansion of innovative healthcare technology and services. Dr. Harrington was a member of one of the first heart transplant teams led by Dr. Jack Copeland from Stanford University. He cofounded one of the first clinical molecular biology laboratories in the U.S. with the Nebraska Lymphoma Study Group headed by Dr. Jim Armitage. Dr. Harrington has developed multiple patents including detection of residual cancer cells, catalytic heavy metal extraction, and a patent pending for diagnosis and classification of cardiac disease. Dr. Harrington has taken over 200 academic discoveries into clinical use, founded a number of public and private biotechnology companies, and his PULS (Protein Unstable Lesion Signature) Cardiac Test was the recipient of the 2016 ABL Grand Prize Award for Innovation in Healthcare. Dr. Harrington is a Clinical Professor at the USC Keck School of Medicine, a published author of numerous peer-reviewed papers, and a sought after speaker in the area of preventive medicine and technology development. Dr. Harrington received his BA in molecular biolgoy, and M.D. from the University of Colorado Health Sciences Center, and is the CEO & Laboratory Director of Predictive Health Diagnostics.
What is Age Management Medicine?
Age Management Medicine is a proactive, preventive approach focused on preservation of optimum human function and quality of life, making every effort to modulate the process of aging prior to the onset of degenerative aging. The basic tenets of Age Management Medicine are patient evaluation through extensive medical history, lifestyle assessment, physical examination and laboratory evaluation to establish personalized proactive treatment plans consisting of proper diet, exercise, stress management and appropriate medical interventions.
About AMMG
It is the goal of the Age Management Medicine Group (AMMG) to provide education and information on the specialty of Age Management Medicine to physicians and healthcare professionals through evidence-based, continuing medical education conferences, workshops, seminars, publications and Web media. The Group consists of leading industry healthcare professionals, physicians, practitioners, researchers, medical
associations and providers of products and services.
Dr. Harrington being interviewed at the AMMG's 23rd Clinical Applications for Age Management Medicine Conference.
Doug Harrington, M.D.
Clinical Professor of Pathology, USC Keck School of Medicine, Los Angeles, CA
CEO & Lab Director, Global Discovery Biosciences, Irvine, CA
Dr. Douglas Harrington has over 25 years of experience in the research, development, commercialization, and expansion of innovative healthcare technology and services. Dr. Harrington was a member of one of the first heart transplant teams led by Dr. Jack Copeland from Stanford University. He cofounded one of the first clinical molecular biology laboratories in the U.S. with the Nebraska Lymphoma Study Group headed by Dr. Jim Armitage. Dr. Harrington has developed multiple patents including detection of residual cancer cells, catalytic heavy metal extraction, and a patent pending for diagnosis and classification of cardiac disease. Dr. Harrington has taken over 200 academic discoveries into clinical use, founded a number of public and private biotechnology companies, and his PULS (Protein Unstable Lesion Signature) Cardiac Test was the recipient of the 2016 ABL Grand Prize Award for Innovation in Healthcare. Dr. Harrington is a Clinical Professor at the USC Keck School of Medicine, a published author of numerous peer-reviewed papers, and a sought after speaker in the area of preventive medicine and technology development. Dr. Harrington received his BA in molecular biolgoy, and M.D. from the University of Colorado Health Sciences Center, and is the CEO & Laboratory Director of Predictive Health Diagnostics.
What is Age Management Medicine?
Age Management Medicine is a proactive, preventive approach focused on preservation of optimum human function and quality of life, making every effort to modulate the process of aging prior to the onset of degenerative aging. The basic tenets of Age Management Medicine are patient evaluation through extensive medical history, lifestyle assessment, physical examination and laboratory evaluation to establish personalized proactive treatment plans consisting of proper diet, exercise, stress management and appropriate medical interventions.
About AMMG
It is the goal of the Age Management Medicine Group (AMMG) to provide education and information on the specialty of Age Management Medicine to physicians and healthcare professionals through evidence-based, continuing medical education conferences, workshops, seminars, publications and Web media. The Group consists of leading industry healthcare professionals, physicians, practitioners, researchers, medical
associations and providers of products and services.
